Klastersky J
Service de Médecine, Institut Jules Bordet, Bruxelles.
Rev Med Brux. 1993 Apr;14(4):102-9.
Our review analyses the rationale for chemotherapy in inoperable non small cell lung cancer. We concluded that such a treatment might be beneficial in about 30% of the patients. It is however a potentially toxic approach; the inconveniences can be reduced by a close follow-up and the use of various techniques of supportive care.
我们的综述分析了不可切除的非小细胞肺癌化疗的基本原理。我们得出结论，这种治疗方法可能对约30%的患者有益。然而，这是一种潜在的有副作用的治疗方法；通过密切随访和使用各种支持性护理技术，可以减少不便之处。
